Rate and risk factors for AKI after CT scans in a cancer cohort

por Latcha, Sheron, Plodkowski, Andrew J., Zheng, Junting, Jaimes, Edgar A.
Publicado en Clin Nephrol (2019)

CT features of HER2-mutant lung adenocarcinomas

por Sawan, Peter, Plodkowski, Andrew J., Li, Angela E., Li, Bob T., Drilon, Alexander, Capanu, Marinela, Ginsberg, Michelle S.
Publicado en Clin Imaging (2018)

CT Appearance of Organizing Pneumonia in an Oncologic Patient Population

por Long, Niamh M., Plodkowski, Andrew J., Schor-Bardach, Rachel, Geyer, Alexander I., Zheng, Junting, Moskowitz, Chaya S, Ginsberg, Michelle S
Publicado en J Comput Assist Tomogr (2017)

Successful Use of Afatinib After Erlotinib-induced Pneumonitis in a Patient With Epidermal Growth Factor Receptor-mutant Lung Cancer

por Jakubowski, Christopher D., Plodkowski, Andrew J., Chang, Jason C., Rekhtman, Natasha, Iqbal, Afsheen, Paik, Paul K., Yu, Helena A.
Publicado en Clin Lung Cancer (2016)

What CT characteristics of lepidic predominant pattern lung adenocarcinomas correlate with invasiveness on pathology?

por Aherne, Emily A., Plodkowski, Andrew J., Montecalvo, Joseph, Hayan, Sumar, Zheng, Junting, Capanu, Marinela, Adusumilli, Prasad S., Travis, William D., Ginsberg, Michelle S.
Publicado en Lung Cancer (2018)

Malignant Pleural Mesothelioma: Are There Imaging Characteristics Associated with Different Histologic Subtypes on Computed Tomography?

por Escalon, Joanna G., Harrington, Kate A., Plodkowski, Andrew J., Zheng, Junting, Capanu, Marinela, Zauderer, Marjorie G., Rusch, Valerie W., Ginsberg, Michelle S.
Publicado en J Comput Assist Tomogr (2018)

Dual-Energy CT Angiography for Detection of Pulmonary Emboli: Incremental Benefit of Iodine Maps

por Weidman, Elizabeth K., Plodkowski, Andrew J., Halpenny, Darragh F., Hayes, Sara A., Perez-Johnston, Rocio, Zheng, Junting, Moskowitz, Chaya, Ginsberg, Michelle S.
Publicado en Radiology (2018)

Pre-treatment CT imaging in stage IIIA lung cancer: can we predict local recurrence after definitive chemoradiotherapy?

por Plodkowski, Andrew J, Araujo-Filho, Jose Arimateia Batista, Simmers, Cameron DA, Girshman, Jeffrey, Raj, Micheal, Zheng, Junting, Rimner, Andreas, Ginsberg, Michelle S
Publicado en Clin Imaging (2020)

From genotype to phenotype: Are there imaging characteristics associated with lung adenocarcinomas harboring RET and ROS1 rearrangements?

por Plodkowski, Andrew J, Drilon, Alexander, Halpenny, Darragh F, O’Driscoll, Dearbhail, Blair, Donald, Litvak, Anya M., Zheng, Junting, Moskowitz, Chaya S, Ginsberg, Michelle S
Publicado en Lung Cancer (2015)

Diagnostic utility and clinical implication of late gadolinium enhancement cardiac magnetic resonance for detection of catheter associated right atrial thrombus

por Plodkowski, Andrew J., Chan, Angel, Gupta, Dipti, Lakhman, Yulia, Kukar, Nina, Kim, Jiwon, Perez-Johnston, Rocio, Ginsberg, Michelle S., Steingart, Richard M., Weinsaft, Jonathan W.
Publicado en Clin Imaging (2020)

Perfusion defects on dual energy CTA in patients with suspected pulmonary embolism correlate with right heart strain and lower survival

por Perez-Johnston, Rocio, Plodkowski, Andrew J., Halpenny, Darragh F., Hayes, Sara A., Capanu, Marinela, Araujo-Filho, J.A.B., Weinsaft, Jonathan W., Ginsberg, Michelle S.
Publicado en Eur Radiol (2020)

Computed tomography-derived assessments of regional muscle volume: Validating their use as predictors of whole body muscle volume in cancer patients

por Halpenny, Darragh F, Goncalves, Marcus, Schwitzer, Emily, Golia Pernicka, Jennifer, Jackson, Jasmyne, Gandelman, Stephanie, Moskowitz, Chaya S, Postow, Michael, Mourtzakis, Marina, Caan, Bette, Jones, Lee W, Plodkowski, Andrew J
Publicado en Br J Radiol (2018)

Prevalence of occult peribronchial N1 nodal metastasis in peripheral clinical N0 <2 cm NSCLC

por Robinson, Eric M., Ilonen, Ilkka K., Tan, Kay See, Plodkowski, Andrew J., Bott, Matthew, Bains, Manjit S., Adusumilli, Prasad S., Park, Bernard J., Rusch, Valerie W., Jones, David R., Huang, James
Publicado en Ann Thorac Surg (2019)

Prognostic utility of differential tissue characterization of cardiac neoplasm and thrombus via late gadolinium enhancement cardiovascular magnetic resonance among patients with ad...

por Chan, Angel T., Plodkowski, Andrew J., Pun, Shawn C., Lakhman, Yuliya, Halpenny, Darragh F., Kim, Jiwon, Goldburg, Samantha R., Matasar, Mathew J., Moskowitz, Chaya S., Gupta, Dipti, Steingart, Richard, Weinsaft, Jonathan W.
Publicado en J Cardiovasc Magn Reson (2017)

Safety of combining thoracic radiation therapy with concurrent versus sequential immune checkpoint inhibition

por von Reibnitz, Donata, Chaft, Jamie E., Wu, Abraham J., Samstein, Robert, Hellmann, Matthew D., Plodkowski, Andrew J., Zhang, Zhigang, Shi, Weiji, Dick-Godfrey, Rosalind, Panchoo, Kelly H., Barker, Christopher A., Rimner, Andreas
Publicado en Adv Radiat Oncol (2018)

Acquired MET Exon 14 Alteration Drives Secondary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in EGFR-Mutated Lung Cancer

por Suzawa, Ken, Offin, Michael, Schoenfeld, Adam J., Plodkowski, Andrew J., Odintsov, Igor, Lu, Daniel, Lockwood, William W., Arcila, Maria E., Rudin, Charles M., Drilon, Alexander, Yu, Helena A., Riely, Gregory J., Somwar, Romel, Ladanyi, Marc
Publicado en JCO Precis Oncol (2019)

Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non–small cell lung cancer and a poor performance status

por Alessi, Joao V, Ricciuti, Biagio, Jiménez-Aguilar, Elizabeth, Hong, Fangxin, Wei, Zihan, Nishino, Mizuki, Plodkowski, Andrew J, Sawan, Peter, Luo, Jia, Rizvi, Hira, Carter, Brett W, Heymach, John V, Altan, Mehmet, Hellmann, Matthew, Awad, Mark
Publicado en J Immunother Cancer (2020)

Efficacy of platinum/pemetrexed combination chemotherapy in ALK-positive non-small cell lung cancer refractory to second-generation ALK inhibitors

por Lin, Jessica J., Schoenfeld, Adam J., Zhu, Viola W., Yeap, Beow Y., Chin, Emily, Rooney, Marguerite, Plodkowski, Andrew J., Digumarthy, Subba R., Dagogo-Jack, Ibiayi, Gainor, Justin F., Ou, Sai-Hong Ignatius, Riely, Gregory J., Shaw, Alice T.
Publicado en J Thorac Oncol (2019)

Safety and Efficacy of Retreating with Immunotherapy After Immune-Related Adverse Events in Patients with NSCLC

por Santini, Fernando C., Rizvi, Hira, Plodkowski, Andrew J., Ni, Andy, Lacouture, Mario E., Gambarin-Gelwan, Maya, Wilkins, Olivia, Panora, Elizabeth, Halpenny, Darragh F., Long, Niamh M., Kris, Mark G., Rudin, Charles M., Chaft, Jamie E., Hellmann, Matthew D.
Publicado en Cancer Immunol Res (2018)

Deep learning to estimate RECIST in patients with NSCLC treated with PD-1 blockade

por Arbour, Kathryn C., Luu, Anh Tuan, Luo, Jia, Rizvi, Hira, Plodkowski, Andrew J., Sakhi, Mustafa, Huang, Kevin B., Digumarthy, Subba R., Ginsberg, Michelle S., Girshman, Jeffrey, Kris, Mark G., Riely, Gregory J., Yala, Adam, Gainor, Justin F., Barzilay, Regina, Hellmann, Matthew D.
Publicado en Cancer Discov (2020)